Business
NTRR Explores Promising Cannabinoid Treatments for Chronic Migraines
NTRR Explores Promising Cannabinoid Treatments for Chronic Migraines.
About this update from Neutra Corp.
[{"type":"text","content":"\n \n As mounting evidence suggests that the administration of cannabis can \n reduce the frequency of migraine headaches, Neutra \n Corp. (OTCQB:NTRR) will explore the promise of advanced cannabinoid \n delivery technologies to ease migraine sufferers’ pain.\n \n \n Data published online ahead of print in the journal Pharmacotherapy \n finds that cannabis administration is clearly associated with decreased \n migraine frequency. The report comes from investigators at the \n University of Colorado, Skaggs School of Pharmacy and Pharmaceutical \n Sciences, who assessed cannabis’ effects on monthly migraine frequency \n in a group of 121 adults. The authors discovered that 85 percent of \n subjects reported a decrease in migraine frequency, with 12 percent \n reporting that use of cannabis prior to a migraine’s onset could prevent \n a headache altogether.\n \n \n Case reports have previously documented positive results for cannabis in \n the treatment of migraines, leading scientists to theorize that \n cannabinoids may have a role to play in migraine regulation.\n \n \n NTRR is working to devise new cannabinoid delivery technologies in order \n to help medical cannabis patients treat their migraines more reliably \n and effectively. In its quest to build a portfolio of wellness-related \n technology assets ripe for commercialization, NTRR is researching \n cutting-edge cannabis inhaler technology, as well as a range of \n cannabis-infused topicals to potentially include lotions, oils and balms.\n \n \n “Cannabis is used to effectively treat all sorts of maladies, so it only \n makes sense that consumers are demanding a wide variety of compatible \n drug delivery methods,” said NTRR CEO Chris Brown. “Inhalers and topical \n salves could provide superior options to patients suffering from \n migraines and debilitating issues.”\n \n \n About Neutra Corp.\n \n \n Neutra Corp. is a healthy lifestyle company that specializes in the \n development and marketing of natural wellness solutions, including \n cannabis-related products. By providing a variety of new technologies \n designed to ensure safer, more reliable access to cannabis in approved \n markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals \n (OTCBB: GWPRF), INSYS Therapeutics, Inc. (NASDAQ: INSY) and ENDEXX Corp. \n (...